These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10535414)

  • 21. Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses.
    Morale MC; Batticane N; Bartoloni G; Guarcello V; Farinella Z; Galasso MG; Marchetti B
    Endocrinology; 1991 Feb; 128(2):1073-85. PubMed ID: 1846575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
    Emons G; Schröder B; Ortmann O; Westphalen S; Schulz KD; Schally AV
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1458-64. PubMed ID: 8263128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity.
    Marchetti B; Guarcello V; Morale MC; Bartoloni G; Raiti F; Palumbo G; Farinella Z; Cordaro S; Scapagnini U
    Endocrinology; 1989 Aug; 125(2):1037-45. PubMed ID: 2546733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiprogestin RU486 dissociates LH and FSH secretion in male rats: evidence for direct action at the pituitary level.
    Sánchez-Criado JE; Bellido C; Tébar M; Ruiz A; Gonzalez D
    J Endocrinol; 1999 Feb; 160(2):197-203. PubMed ID: 9924188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line.
    Arencibia JM; Schally AV
    Int J Oncol; 2000 May; 16(5):1009-13. PubMed ID: 10762638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
    Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
    Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of single parenteral indomethacin injection in rat fundic and antral epithelial proliferation.
    Kuwayama H; Nakajima N; Matsuo Y; Eastwood GL
    J Clin Gastroenterol; 1990; 12 Suppl 1():S72-5. PubMed ID: 2212552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist: short- and long-term effects.
    Garnelo P; Pinilla L; Gaytan F; Aguilar E
    J Endocrinol; 1992 Aug; 134(2):269-77. PubMed ID: 1402537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging diminishes gastric mucosal regeneration: relationship to tyrosine kinases.
    Fligiel SE; Relan NK; Dutta S; Tureaud J; Hatfield J; Majumdar AP
    Lab Invest; 1994 May; 70(5):764-74. PubMed ID: 8196370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of luteinizing hormone-releasing hormone (LHRH) treatment on cellular proliferation in the rat anterior pituitary.
    Carbajo S; González F; López-Muñiz A; Carbajo-Pérez E
    Histol Histopathol; 1994 Apr; 9(2):275-9. PubMed ID: 8075486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a luteinizing hormone-releasing hormone antagonist in late-juvenile female rats: blockade of follicle growth and delay of first ovulation following suppression of gonadotropin concentrations.
    Meijs-Roelofs HM; Kramer P; Van Cappellen WA; Van Leeuwen EC
    Biol Reprod; 1990 Oct; 43(4):607-13. PubMed ID: 2126964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function.
    Marchetti B; Guarcello V; Morale MC; Bartoloni G; Farinella Z; Cordaro S; Scapagnini U
    Endocrinology; 1989 Aug; 125(2):1025-36. PubMed ID: 2546732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II is retained in gonadotrophs of pituitary cell aggregates cultured in serum-free medium but does not mimic the effects of exogenous angiotensins and luteinizing-hormone-releasing hormone on growth hormone release.
    Robberecht W; Andries M; Denef C
    Neuroendocrinology; 1992 Oct; 56(4):550-60. PubMed ID: 1475013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of mucosal cell proliferation following acute aspirin injury in rat stomach.
    Ohning GV; Guth PH
    Dig Dis Sci; 1995 Jun; 40(6):1351-6. PubMed ID: 7781459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term sucralfate ingestion on antral and fundic epithelial proliferation in the rat.
    Kuwayama H
    Dig Dis Sci; 1996 May; 41(5):979-83. PubMed ID: 8625772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of luteinizing hormone releasing hormone (LHRH) in milk.
    Smith SS; Ojeda SR
    Endocrinol Exp; 1986 Aug; 20(2-3):147-53. PubMed ID: 3019631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
    Kalra PS; Fuentes M; Sahu A; Kalra SP
    Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of LHRH agonists on the growth of human prostatic tumor cells: "in vitro" and "in vivo" studies.
    Montagnani Marelli M; Moretti RM; Dondi D; Limonta P; Motta M
    Arch Ital Urol Androl; 1997 Sep; 69(4):257-63. PubMed ID: 9396187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release.
    Faletti AG; Mastronardi CA; Lomniczi A; Seilicovich A; Gimeno M; McCann SM; Rettori V
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1722-6. PubMed ID: 9990091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.